ArticleMolecular cancer2020

Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer.

Wenjing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.